La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Tyrosine 3-Monooxygenase (metabolism) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Tyrosine 3-Monooxygenase (immunology) < Tyrosine 3-Monooxygenase (metabolism) < Tyrosine 3-Monooxygenase (physiology)  Facettes :

List of bibliographic references indexed by Tyrosine 3-Monooxygenase (metabolism)

Number of relevant bibliographic references: 36.
[0-20] [0 - 20][0 - 36][20-35][20-40]
Ident.Authors (with country if any)Title
000153 (2016) Qing He [République populaire de Chine] ; James B. Koprich [Canada] ; Ying Wang [République populaire de Chine] ; Wen-Bo Yu [République populaire de Chine] ; Bao-Guo Xiao [République populaire de Chine] ; Jonathan M. Brotchie [Canada] ; Jian Wang [République populaire de Chine]Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease.
000579 (2015) R T Bartus [États-Unis] ; J H Kordower [États-Unis] ; E M Johnson [États-Unis] ; L. Brown [États-Unis] ; B R Kruegel [États-Unis] ; Y. Chu [États-Unis] ; T L Baumann [États-Unis] ; A E Lang [Canada] ; C W Olanow [États-Unis] ; C D Herzog [États-Unis]Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with α-synucleinopathies.
000648 (2015) Yueting Shao [Canada] ; Daniel Figeys ; Zhibin Ning ; Ryan Mailloux ; Hing Man ChanMethylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells.
000678 (2015) Ross B. Mounsey [Royaume-Uni] ; Sarah Mustafa [Royaume-Uni] ; Lianne Robinson [Royaume-Uni] ; Ruth A. Ross [Canada] ; Gernot Riedel [Royaume-Uni] ; Roger G. Pertwee [Royaume-Uni] ; Peter Teismann [Royaume-Uni]Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
000993 (2014) C H Carriere [Canada] ; N H Kang [Canada] ; L P Niles [Canada]Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease.
000B35 (2014) Matthew D. Walker [Canada] ; Mattia Volta [Canada] ; Stefano Cataldi [Canada] ; Katherine Dinelle [Canada] ; Dayne Beccano-Kelly [Canada] ; Lise Munsie [Canada] ; Rick Kornelsen [Canada] ; Chenoa Mah [Canada] ; Patrick Chou [Canada] ; Kimberley Co [Canada] ; Jaskaran Khinda [Canada] ; Marta Mroczek [Canada] ; Sabrina Bergeron [Canada] ; Katrina Yu [Canada] ; Li Ping Cao [Canada] ; Natalja Funk [Allemagne] ; Thomas Ott [Allemagne] ; Dagmar Galter [Suède] ; Olaf Riess [Allemagne] ; Saskia Biskup [Allemagne] ; Austen J. Milnerwood [Canada] ; A Jon Stoessl [Canada] ; Matthew J. Farrer [Canada] ; Vesna Sossi [Canada]Behavioral deficits and striatal DA signaling in LRRK2 p.G2019S transgenic rats: a multimodal investigation including PET neuroimaging.
000E04 (2013) Scott Mackey [États-Unis] ; Yu Jing ; Joseph Flores ; Katie Dinelle ; Doris J. DoudetDirect intranigral administration of an ubiquitin proteasome system inhibitor in rat: behavior, positron emission tomography, immunohistochemistry.
001610 (2011) James B. Koprich ; Tom H. Johnston ; Philippe Huot ; M. Gabriela Reyes ; Maria Espinosa ; Jonathan M. BrotchieProgressive Neurodegeneration or Endogenous Compensation in an Animal Model of Parkinson's Disease Produced by Decreasing Doses of Alpha-Synuclein
001A45 (2010) Joseph P. Steiner [États-Unis] ; Kathryn B. Payne ; Christopher Drummond Main ; Sabrina D'Alfonso ; Kirsten X. Jacobsen ; T Philip Hicks ; William A. Staines ; Michael O. PoulterGPI-1046 increases presenilin-1 expression and restores NMDA channel activity.
001E00 (2009) Mallika Somayajulu-Ni U [Canada] ; Jagdeep K. Sandhu [Canada] ; Jerome Cohen [Canada] ; Marianna Sikorska [Canada] ; Ts Sridhar [Canada, Inde] ; Anca Matei [Canada] ; Henryk Borowy-Borowski [Canada] ; Siyaram Pandey [Canada]Paraquat induces oxidative stress, neuronal loss in substantia nigra region and Parkinsonism in adult rats: Neuroprotection and amelioration of symptoms by water-soluble formulation of Coenzyme Q10
002144 (2008) Vicky Lahaie-Collins ; Julie Bournival ; Marilyn Plouffe ; Julie Carange ; Maria-Grazia MartinoliSesamin modulates tyrosine hydroxylase, superoxide dismutase, catalase, inducible NO synthase and interleukin-6 expression in dopaminergic cells under MPP+-induced oxidative stress
002358 (2008) M. Quinn [Canada] ; K. Mukhida [Canada] ; D. Sadi [Canada] ; M. Hong [Canada] ; I. MendezAdjunctive use of the non‐ionic surfactant Poloxamer  188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease
002449 (2007) B. Rajakumar [Canada] ; B A Flumerfelt ; A W Hrycyshyn ; N. RajakumarNitric oxide-containing neurons in long-term grafts in a rat model of Parkinson's disease.
002537 (2007) Anne M. Landau [Canada] ; Edouard Kouassi [Canada] ; Rosmarie Siegrist-Johnstone [Canada] ; Julie Desbarats [Canada]Proteasome inhibitor model of Parkinson's disease in mice is confounded by neurotoxicity of the ethanol vehicle
002553 (2007) Rohita Sharma [Canada] ; Catherine R. Mcmillan [Canada] ; Lennard P. Niles [Canada]Neural stem cell transplantation and melatonin treatment in a 6‐hydroxydopamine model of Parkinson’s disease
002683 (2007) Philippe Huot [Canada] ; André Parent [Canada]Dopaminergic neurons intrinsic to the striatum
002904 (2006) Evelyn F. Field [Canada] ; Gerlinde A. Metz [Canada] ; Sergio M. Pellis [Canada] ; Ian Q. Whishaw [Canada]Sexually dimorphic postural adjustments during vertical behaviour are altered in a unilateral 6-OHDA rat model of Parkinson's disease
002915 (2006) Rohita Sharma [Canada] ; Catherine R. Mcmillan [Canada] ; Catherine C. Tenn [Canada] ; Lennard P. Niles [Canada]Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease
002952 (2005) Kelly K. Meissner [Canada] ; David L. Kirkham ; Laurie C. DoeringTransplants of neurosphere cell suspensions from aged mice are functional in the mouse model of Parkinson's.
002988 (2005) Michel St-Hilaire [Canada] ; Eric Landry ; Daniel Lévesque ; Claude RouillardDenervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
002A09 (2005) K. Adam Baker [Canada] ; Ivar Mendez [Canada]Long distance selective fiber outgrowth of transplanted hNT neurons in white matter tracts of the adult rat brain

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Tyrosine 3-Monooxygenase (metabolism)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Tyrosine 3-Monooxygenase (metabolism)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Tyrosine 3-Monooxygenase (metabolism)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022